Keith Manchester

About Keith Manchester

Keith Manchester is a director at Roivant Sciences.

Form D filings name Keith Manchester as a director at Kriya Therapeutics.

Keith Manchester reports to the SEC as a director of 3 public companies, including Arbutus Biopharma (ABUS) and Myovant Sciences (MYOV).

Keith Manchester first appears on SEC filings in 2015.

Experience

This experience comes from SEC filings. The years are when the filings name Keith Manchester in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Keith Manchester works with at each company, as listed on that company's latest Form D.

Sources

1. SECKriya Therapeutics, Inc. Form D/A, filed Sep 10, 2025
2. SECForms 3, 4 and 5 filed by Keith Manchester (SEC filer 1244828)